))
EXTENDED: The ‘Chemical Vaccine’ for Long-Lasting Malaria Prevention (with Theresa Shapiro)
Manage episode 386207095 series 3531530
Contenuto fornito da Johns Hopkins Malaria Research Institute and Johns Hopkins Bloomberg School of Public Health. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Johns Hopkins Malaria Research Institute and Johns Hopkins Bloomberg School of Public Health o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
An old malaria drug gets a new formulation. But how good is it – and will it drive resistance?
In this podcast, we ask:
- What are the limitations of current malaria vaccines?
- What is the concept of long-acting injectable (LAI) drugs?
- What are the clinical and chemical properties of atovaquone that make it suitable for this purpose?
With Theresa Shapiro, Professor, Johns Hopkins School of Medicine and Division Director, Division of Clinical Pharmacology.
About The PodcastThe Johns Hopkins Malaria Minute is produced by the Johns Hopkins Malaria Research Institute to highlight impactful malaria research and to share it with the global community.
68 episodi
Condividi
